Since biological processes occur at the nanoscale, the potential for using nanotechnology to develop new diagnostics and therapeutics for cancer is vast. For example, nanoparticles capable of exclusively targeting tumor cells and not harming healthy cells would dramatically reduce unwanted side effects. Such nanoparticle drug delivery systems could also allow clinicians to resurrect powerful chemotherapeutic agents that were abandoned due to their high toxicity.

In order to engage and inform the clinical community about recent advances at the convergence of nanotechnology and cancer, the IIN sponsors Nano Boot Camps for Clinicians in partnership with the Robert H. Lurie Comprehensive Cancer Center.

This symposium provides an excellent way for clinicians and medical students to gain an understanding of nanotechnology, the current advances in the field, and the prospects for translating these advances to the clinic.

For information on upcoming Nano Boot Camps for Clinicians, please contact Margaret Connolly.